A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Effect of ATI-7505 [naronapride] on Gastric Emptying and Small Bowel and Colonic Transit in Healthy Volunteers.

Trial Profile

A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Effect of ATI-7505 [naronapride] on Gastric Emptying and Small Bowel and Colonic Transit in Healthy Volunteers.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 02 Apr 2010

At a glance

  • Drugs Naronapride (Primary)
  • Indications Constipation; Gastro-oesophageal reflux; Non-ulcer dyspepsia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top